AL
EBS icon

AJO LP’s Emergent Biosolutions EBS Stock Holding History

AJO LP’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-54,222
Closed -$1.57M – 591
2017
Q1 		$1.57M Sell
54,222
-32,495
-37% -$989K 0.01% 386
2016
Q4 		$2.85M Sell
86,717
-56,559
-39% -$1.7M 0.01% 319
2016
Q3 		$4.52M Sell
143,276
-308,714
-68% -$8.97M 0.02% 288
2016
Q2 		$12.7M Buy
451,990
+24,057
+6% +$943K 0.06% 205
2016
Q1 		$15.6M Buy
427,933
+87,758
+26% +$3.1M 0.07% 200
2015
Q4 		$13.6M Sell
340,175
-26,545
-7% -$926K 0.06% 207
2015
Q3 		$10.4M Sell
366,720
-20,400
-5% -$672K 0.05% 232
2015
Q2 		$12.8M Buy
+387,120
New +$12M 0.05% 216
2014
Q2 		– Sell
-17,800
Closed -$450K – 453
2014
Q1 		$450K Buy
+17,800
New +$450K ﹤0.01% 364

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AJO LP's EBS Position: Q2 2017 in Review

AJO LP sold out of Emergent Biosolutions (EBS) in Q2 2017, closing a stake of 54,222 shares — an estimated $1.57M sold.

AJO LP first reported a position in EBS in Q1 2014 and held it in 9 quarters. The position peaked at $15.6M in Q1 2016. 181 funds tracked by Wall St. Rank hold EBS as of Q2 2017.

  • AJO LP reported no remaining Emergent Biosolutions position as of Q2 2017 after selling out during the quarter.
  • AJO LP sold 54,222 Emergent Biosolutions shares in Q2 2017, an estimated $1.57M.
  • AJO LP first reported a position in Emergent Biosolutions in Q1 2014 and held it in 9 quarters.
  • AJO LP's Emergent Biosolutions position peaked at $15.6M in Q1 2016.
  • 181 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2017.

Based on AJO LP's 13F filing for Q2 2017, filed 10 Aug 2017.